Israel Discount Bank of New York’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $228K | Buy |
+1,055
| New | +$202K | 0.42% | 39 |
|
|
2025
Q4 | – | Sell |
-1,453
| Closed | -$204K | – | 39 |
|
|
2025
Q3 | $204K | Buy |
+1,453
| New | +$196K | 0.6% | 41 |
|
|
2025
Q1 | – | Sell |
-1,405
| Closed | -$215K | – | 35 |
|
|
2024
Q4 | $215K | Buy |
1,405
+82
| +6% | +$13.8K | 0.16% | 41 |
|
|
2024
Q3 | $256K | Buy |
1,323
+82
| +7% | +$17.2K | 0.38% | 37 |
|
|
2024
Q2 | $288K | Sell |
1,241
-382
| -24% | -$83K | 0.46% | 36 |
|
|
2024
Q1 | $350K | Sell |
1,623
-503
| -24% | -$118K | 0.44% | 49 |
|
|
2023
Q4 | $550K | Sell |
2,126
-84
| -4% | -$20.6K | 0.43% | 49 |
|
|
2023
Q3 | $568K | Buy |
2,210
+19
| +0.9% | +$5.08K | 0.47% | 42 |
|
|
2023
Q2 | $624K | Sell |
2,191
-247
| -10% | -$73.5K | 0.5% | 40 |
|
|
2023
Q1 | $678K | Sell |
2,438
-19
| -0.8% | -$5.26K | 0.51% | 43 |
|
|
2022
Q4 | $681K | Buy |
2,457
+416
| +20% | +$117K | 0.58% | 44 |
|
|
2022
Q3 | $545K | Sell |
2,041
-485
| -19% | -$103K | 0.45% | 55 |
|
|
2022
Q2 | $515K | Buy |
+2,526
| New | +$516K | 0.39% | 61 |
|
|
2021
Q4 | – | Sell |
-918
| Closed | -$260K | – | 88 |
|
|
2021
Q3 | $260K | Buy |
+918
| New | +$301K | 0.18% | 81 |
|
|
2020
Q4 | – | Sell |
-710
| Closed | -$202K | – | 82 |
|
|
2020
Q3 | $202K | Buy |
+710
| New | +$198K | 0.13% | 85 |
|
|
2020
Q2 | – | Sell |
-1,319
| Closed | -$417K | – | 87 |
|
|
2020
Q1 | $417K | Sell |
1,319
-660
| -33% | -$200K | 0.32% | 69 |
|
|
2019
Q4 | $588K | Buy |
1,979
+55
| +3% | +$15.3K | 0.39% | 61 |
|
|
2019
Q3 | $447K | Sell |
1,924
-20
| -1% | -$4.66K | 0.33% | 66 |
|
|
2019
Q2 | $454K | Buy |
1,944
+84
| +5% | +$19.4K | 0.34% | 64 |
|
|
2019
Q1 | $440K | Buy |
1,860
+19
| +1% | +$5.98K | 0.3% | 63 |
|
|
2018
Q4 | $554K | Sell |
1,841
-140
| -7% | -$44.7K | 0.43% | 47 |
|
|
2018
Q3 | $700K | Sell |
1,981
-389
| -16% | -$134K | 0.46% | 46 |
|
|
2018
Q2 | $688K | Sell |
2,370
-54
| -2% | -$15.2K | 0.45% | 42 |
|
|
2018
Q1 | $664K | Sell |
2,424
-36
| -1% | -$11.2K | 0.44% | 46 |
|
|
2017
Q4 | $784K | Sell |
2,460
-415
| -14% | -$133K | 0.54% | 34 |
|
|
2017
Q3 | $900K | Sell |
2,875
-380
| -12% | -$113K | 0.67% | 24 |
|
|
2017
Q2 | $884K | Sell |
3,255
-15
| -0.5% | -$3.97K | 0.71% | 26 |
|
|
2017
Q1 | $894K | Buy |
3,270
+650
| +25% | +$184K | 0.73% | 31 |
|
|
2016
Q4 | $743K | Buy |
+2,620
| New | +$777K | 0.67% | 31 |
|
Other funds holding BIIB
Israel Discount Bank of New York's BIIB Position: Q2 2026 in Review
Israel Discount Bank of New York opened a new position in Biogen (BIIB) in Q2 2026: 1,055 shares worth $228K. The stake represents 0.42% of the portfolio and ranks #39 among its holdings. This is a return to the name: Israel Discount Bank of New York previously reported a position in BIIB as recently as Q3 2025.
Israel Discount Bank of New York first reported a position in BIIB in Q4 2016 and has held it in 29 quarters since. The position peaked at $900K in Q3 2017. 746 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Israel Discount Bank of New York held 1,055 shares of Biogen worth $228K as of Q2 2026.
- Biogen was a new Israel Discount Bank of New York position in Q2 2026.
- Biogen made up 0.42% of Israel Discount Bank of New York's portfolio in Q2 2026, its #39 holding.
- Israel Discount Bank of New York first reported a position in Biogen in Q4 2016 and has held it in 29 quarters since.
- Israel Discount Bank of New York's Biogen position peaked at $900K in Q3 2017.
- 746 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Israel Discount Bank of New York's 13F filing for Q2 2026, filed 7 Jul 2026.